Range Low Price High Price Comment
30 days $61.33 $81.33 Thursday, 28th Mar 2024 CYTK stock ended at $70.11. This is 1.82% less than the trading day before Wednesday, 27th Mar 2024. During the day the stock fluctuated 2.71% from a day low at $69.96 to a day high of $71.86.
90 days $61.33 $110.00
52 weeks $25.98 $110.00

Historical Cytokinetics prices

Date Open High Low Close Volume
2023-12-08 $34.60 $35.60 $33.60 $34.10 1 596 116
2023-12-07 $33.48 $35.62 $33.36 $34.86 1 696 984
2023-12-06 $32.68 $34.22 $32.50 $33.46 1 481 887
2023-12-05 $33.62 $33.93 $32.54 $32.56 1 221 615
2023-12-04 $33.65 $34.97 $33.38 $33.89 1 356 410
2023-12-01 $33.53 $33.58 $32.39 $33.57 1 693 595
2023-11-30 $32.62 $34.11 $32.36 $33.48 2 487 416
2023-11-29 $31.43 $34.10 $31.43 $32.14 1 772 828
2023-11-28 $31.73 $31.73 $30.68 $31.22 689 082
2023-11-27 $31.87 $32.18 $30.92 $31.83 891 574
2023-11-24 $31.61 $32.20 $31.59 $31.97 380 184
2023-11-22 $32.40 $32.70 $31.46 $31.91 572 301
2023-11-21 $31.70 $32.25 $30.70 $31.74 1 262 581
2023-11-20 $32.67 $33.15 $31.80 $32.31 2 129 983
2023-11-17 $31.95 $32.53 $31.53 $32.44 1 243 394
2023-11-16 $32.78 $33.02 $31.03 $31.68 1 480 165
2023-11-15 $33.63 $35.22 $32.82 $32.83 1 687 308
2023-11-14 $33.38 $34.40 $33.02 $34.29 1 406 379
2023-11-13 $31.84 $33.05 $31.60 $32.01 1 542 389
2023-11-10 $33.12 $33.81 $32.33 $32.50 1 471 780
2023-11-09 $35.40 $35.74 $33.05 $33.11 812 925
2023-11-08 $35.63 $35.76 $34.49 $34.76 921 950
2023-11-07 $35.45 $36.00 $34.91 $35.85 1 254 095
2023-11-06 $35.78 $36.28 $33.61 $34.43 1 456 598
2023-11-03 $35.45 $36.78 $35.01 $36.32 2 029 793
Click to get the best stock tips daily for free!

About Cytokinetics

Cytokinetics Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates include omecamtiv mecarbil, a novel cardiac myosin activator that is in Phase III clinical trial in pati... CYTK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT